Cargando…

Pancreatitis in tigecycline Phase 3 and 4 clinical studies

OBJECTIVES: To examine the incidence of pancreatitis among subjects enrolled in the tigecycline clinical trial programme, summarize cases and examine concomitant use of other pancreatitis-causing medications. METHODS: Subject data from Phase 3 and 4 comparative tigecycline studies were included in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGovern, Paul C., Wible, Michele, Korth-Bradley, Joan M., Quintana, Alvaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922153/ https://www.ncbi.nlm.nih.gov/pubmed/24216769 http://dx.doi.org/10.1093/jac/dkt427

Ejemplares similares

Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials
por: Tucker, Hal, et al.
Publicado: (2017)

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections
por: Matthews, Peter, et al.
Publicado: (2012)

The Spectrum of Tigecycline-Induced Pancreatitis in Clinical Characteristics, Diagnosis, and Management
por: Pan, Juan, et al.
Publicado: (2023)

700. Safety and Efficacy of Omadacycline in Patients with Diabetes in Phase 3 Clinical Studies
por: Pai, Manjunath P, et al.
Publicado: (2019)

Tigecycline Tango: A Case of Antibiotic-Induced Pancreatitis
por: Maringanti, Babu Sriram, et al.
Publicado: (2023)

A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China
por: Chen, Yijian, et al.
Publicado: (2018)

In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for hospital acquired pneumonia
por: Petersen, Peter J., et al.
Publicado: (2010)

Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness
por: Baron, Jeffrey, et al.
Publicado: (2018)

Acute pancreatitis caused by tigecycline: A case report and literature review
por: Wang, Peng-fei, et al.
Publicado: (2021)

Clinical Experience with Tigecycline in the Treatment of Prosthetic Joint Infections
por: Lastinger, Allison, et al.
Publicado: (2019)

Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT)
por: Vogel, Arndt, et al.
Publicado: (2016)

Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score–Matched Analysis
por: Solomkin, Joseph, et al.
Publicado: (2016)

Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection
por: Yu, Meiling, et al.
Publicado: (2023)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

Presence of Mobile Tigecycline Resistance Gene tet(X4) in Clinical Klebsiella pneumoniae
por: Zhai, Weishuai, et al.
Publicado: (2022)

Clinical Experience with Tigecycline in the Treatment of Prosthetic Joint Infections
por: Lastinger, Allison, et al.
Publicado: (2017)

Clinical Manifestations and Risk Factors of Tigecycline-Associated Thrombocytopenia
por: Zhu, Yuanchao, et al.
Publicado: (2023)

Tigecycline Induced Hyperpigmentation of the Skin
por: Vandecasteele, S. J., et al.
Publicado: (2016)

Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004–2013
por: Hoban, Daryl J, et al.
Publicado: (2015)

A Novel Tigecycline Adjuvant ML-7 Reverses the Susceptibility of Tigecycline-Resistant Klebsiella pneumoniae
por: Sun, Lilan, et al.
Publicado: (2022)

Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies
por: Sakoulas, George, et al.
Publicado: (2021)

A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia
por: Reed, Gregory A., et al.
Publicado: (2016)

110. Clinical Outcomes of Patients with Secondary Bacteremia in the Omadacycline Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies
por: Sakoulas, George, et al.
Publicado: (2019)

An Exploration of the Psycho-Social Benefits of Providing Sponsorship and Supporting Others in Traditional 12 Step, Self-Help Groups
por: McGovern, William, et al.
Publicado: (2021)

Tigecycline for Severe Rickettsioses: Gained Experience Needing a Slight Grain of Salt
por: Blanton, Lucas S., et al.
Publicado: (2022)

Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii
por: Jo, Jeongwoo, et al.
Publicado: (2021)

Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections
por: Pai, Manjunath P, et al.
Publicado: (2021)

The SSRI Clinic: Improving SSRI Prescribing Safety in Outpatient CAMHS Clinic
por: Morgan, Tammy, et al.
Publicado: (2022)

Effects of tigecycline and doxycycline in porcine endotoxemia
por: Von Seth, M, et al.
Publicado: (2011)

Therapy of intracellular Staphylococcus aureus by tigecyclin
por: Kreis, Carolin A, et al.
Publicado: (2013)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020)

Risk Factors for Tigecycline-Associated Hypofibrinogenemia
por: Liu, Jia, et al.
Publicado: (2021)

Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023)

Tigecycline Absorption Improved by Selected Excipients
por: Ziółkowski, Hubert, et al.
Publicado: (2023)

658. Diagnostic Testing Among Patients with Suspected Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III a Phase 3 Clinical Trial: Implications for Clinical Practice vs Clinical Trials
por: Sims, Matthew, et al.
Publicado: (2021)

Intra-abdominal infection after tumor surgery: tigecycline combined with β-lactam antibiotics versus tigecycline alone
por: Cai, Xinfeng, et al.
Publicado: (2023)

2513. CERTAIN-1 Subgroup Analysis: A Phase 3 Study of Cefepime-Taniborbactam Efficacy in the Treatment of Complicated Urinary Tract Infections (cUTI)
por: Dorr, Mary Beth, et al.
Publicado: (2023)

Tigecycline-induced acute pancreatitis in a renal transplant patient: a case report and literature review
por: Lin, Jinwen, et al.
Publicado: (2018)

Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
por: Shin, Jung Ar, et al.
Publicado: (2012)

Detection and characterization of tigecycline heteroresistance in E. cloacae: clinical and microbiological findings
por: Liu, Hang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kl75hfvk6hrm8fmi9qkgk4h47a